According to Race Oncology's latest financial reports the company's current EPS (TTM) is -$0.06492. In 2023 the company made an earnings per share (EPS) of -$0.06492 an increase over its 2022 EPS that were of -$0.07962.
Year | EPS | Change |
---|---|---|
2023 | -$0.06492 | -18.46% |
2022 | -$0.07962 | 37.74% |
2021 | -$0.05780 | 47% |
2020 | -$0.03932 | -23.41% |
2019 | -$0.05134 | -53.58% |
2018 | -$0.11 | 14.62% |
2017 | -$0.09650 | 190.27% |
2016 | -$0.03325 | |
2015 | N/A |